Sei Investments CO Chinook Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$21.53 - $26.8 $56,580 - $70,430	-2,628 Reduced 13.86%	16,329 $378,000
Q4 2022 Feb 10, 2023	SELL	$18.63 - $27.35 $69,154 - $101,523	-3,712 Reduced 16.37%	18,957 $496,000
Q3 2022 Nov 14, 2022	SELL	$17.51 - $23.37 $12,432 - $16,592	-710 Reduced 3.04%	22,669 $446,000
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $294,341 - $439,525	23,379 New	23,379 $409,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.